دورية أكاديمية
أعرض في EDS

BCG Vaccine-The Road Not Taken.

التفاصيل البيبلوغرافية
العنوان: BCG Vaccine-The Road Not Taken.
المؤلفون: Dow CT; Department of Ophthalmology and Visual Sciences, McPherson Eye Research Institute, Madison, WI 53705, USA.; Mindful Diagnostics and Therapeutics, Eau Claire, WI 54701, USA., Kidess L; Department of Biochemistry, University of St. Thomas, St. Paul, MN 55105, USA.
المصدر: Microorganisms [Microorganisms] 2022 Sep 27; Vol. 10 (10). Date of Electronic Publication: 2022 Sep 27.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101625893 Publication Model: Electronic Cited Medium: Print ISSN: 2076-2607 (Print) Linking ISSN: 20762607 NLM ISO Abbreviation: Microorganisms Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2013]-
مستخلص: The Bacillus Calmette-Guérin (BCG) vaccine has been used for over one hundred years to protect against the most lethal infectious agent in human history, tuberculosis. Over four billion BCG doses have been given and, worldwide, most newborns receive BCG. A few countries, including the United States, did not adopt the WHO recommendation for routine use of BCG. Moreover, within the past several decades, most of Western Europe and Australia, having originally employed routine BCG, have discontinued its use. This review article articulates the impacts of those decisions. The suggested consequences include increased tuberculosis, increased infections caused by non-tuberculous mycobacteria (NTM), increased autoimmune disease (autoimmune diabetes and multiple sclerosis) and increased neurodegenerative disease (Parkinson's disease and Alzheimer's disease). This review also offers an emerged zoonotic pathogen, Mycobacterium avium ss. paratuberculosis (MAP), as a mostly unrecognized NTM that may have a causal role in some, if not all, of these diseases. Current clinical trials with BCG for varied infectious, autoimmune and neurodegenerative diseases have brought this century-old vaccine to the fore due to its presumed immuno-modulating capacity. With its historic success and strong safety profile, the new and novel applications for BCG may lead to its universal use-putting the Western World back onto the road not taken.
References: PLoS One. 2011 Jan 31;6(1):e16610. (PMID: 21304945)
Front Microbiol. 2020 Mar 11;11:332. (PMID: 32218774)
Trans R Soc Trop Med Hyg. 1976;70(5-6):449-57. (PMID: 841647)
Infect Immun. 2004 Jan;72(1):62-5. (PMID: 14688081)
Med Hypotheses. 1999 Feb;52(2):95-9. (PMID: 10340288)
J Neurol. 2003 Feb;250(2):247-8. (PMID: 12622098)
World J Urol. 2019 Oct;37(10):2017-2029. (PMID: 30535583)
Tuber Lung Dis. 1994 Jun;75(3):179-80. (PMID: 7919307)
Tuber Lung Dis. 1994 Oct;75(5):348-52. (PMID: 7841428)
J Neuroimmunol. 2021 Oct 15;359:577694. (PMID: 34450375)
Tubercle. 1987 Dec;68(4):291-6. (PMID: 3138802)
Curr Trop Med Rep. 2018;5(4):247-256. (PMID: 30460172)
Cold Spring Harb Perspect Med. 2014 Jun 02;4(6):. (PMID: 24890836)
Curr Opin Immunol. 2018 Dec;55:89-96. (PMID: 30447407)
Cell Rep. 2016 Dec 6;17(10):2562-2571. (PMID: 27926861)
JAMA. 2004 May 5;291(17):2086-91. (PMID: 15126436)
Front Vet Sci. 2018 Oct 26;5:259. (PMID: 30417002)
NPJ Vaccines. 2018 Jun 21;3:23. (PMID: 29951281)
Neurobiol Dis. 2017 May;101:27-39. (PMID: 28189498)
Clin Exp Immunol. 2010 Apr;160(1):70-9. (PMID: 20415854)
Med Hypotheses. 2019 Feb;123:95-97. (PMID: 30696606)
J Pathol Bacteriol. 1948 Jan;60(1):93-122. (PMID: 18876541)
CMAJ. 2001 Nov 27;165(11):1495-8. (PMID: 11762573)
Tuber Lung Dis. 1995 Aug;76(4):300-10. (PMID: 7579311)
Alzheimers Dement (N Y). 2018 Sep 06;4:575-590. (PMID: 30406177)
Lancet Infect Dis. 2006 Mar;6(3):162-70. (PMID: 16500597)
Vaccine. 2021 Dec 8;39(50):7341-7352. (PMID: 34417052)
Trends Immunol. 2013 Sep;34(9):431-9. (PMID: 23680130)
PLoS Pathog. 2016 Jan 21;12(1):e1005271. (PMID: 26794678)
BMC Infect Dis. 2016 May 06;16:195. (PMID: 27154015)
J Transl Autoimmun. 2021 Feb 05;4:100085. (PMID: 33665595)
Acta Neuropathol. 2011 Aug;122(2):187-204. (PMID: 21720849)
J Exp Med. 2022 Aug 1;219(8):. (PMID: 35731195)
Am Rev Respir Dis. 1966 Oct;94(4):553-68. (PMID: 5924215)
Neurology. 2014 Jan 7;82(1):41-8. (PMID: 24306002)
Vaccine. 2018 Sep 18;36(39):5902-5909. (PMID: 30143270)
Lancet Infect Dis. 2022 Jan;22(1):e2-e12. (PMID: 34506734)
Brain. 2022 Sep 14;145(9):3058-3071. (PMID: 35722765)
Lancet. 2021 Jun 12;397(10291):2284-2303. (PMID: 33848468)
Int J Epidemiol. 2022 Oct 13;51(5):1637-1644. (PMID: 35278068)
Expert Rev Vaccines. 2010 Feb;9(2):209-22. (PMID: 20109030)
J Alzheimers Dis. 2021;83(4):1825-1839. (PMID: 34459398)
Maedica (Bucur). 2013 Mar;8(1):53-8. (PMID: 24023600)
Proc R Soc Med. 1931 Sep;24(11):1481-90. (PMID: 19988326)
Bull World Health Organ. 1990;68(1):93-108. (PMID: 2189588)
Immunobiology. 2021 Jan;226(1):152052. (PMID: 33418320)
BMC Infect Dis. 2018 Apr 10;18(1):163. (PMID: 29631541)
PLoS One. 2019 Nov 7;14(11):e0224433. (PMID: 31697701)
Microorganisms. 2020 Aug 10;8(8):. (PMID: 32784941)
Respir Med. 2020 Nov;173:106164. (PMID: 32992265)
PLoS One. 2008;3(10):e3426. (PMID: 18923677)
Wkly Epidemiol Rec. 2003 May 9;78(19):163-8. (PMID: 12762169)
J Clin Invest. 2001 Jul;108(1):63-72. (PMID: 11435458)
Vaccine. 2021 Sep 15;39(39):5524-5531. (PMID: 34420785)
Lancet. 1996 Jul 6;348(9019):17-24. (PMID: 8691924)
Trop Geogr Med. 1959 Dec;11:293-312. (PMID: 14406764)
Trends Endocrinol Metab. 2019 Feb;30(2):80-92. (PMID: 30600132)
Vaccines (Basel). 2021 May 11;9(5):. (PMID: 34064775)
J Infect Dis. 2018 Jul 24;218(5):679-687. (PMID: 29635431)
Microorganisms. 2022 Feb 12;10(2):. (PMID: 35208878)
Ann Am Thorac Soc. 2015 May;12(5):642-7. (PMID: 25692495)
Front Immunol. 2021 Aug 05;12:714179. (PMID: 34421917)
Front Immunol. 2020 May 08;11:760. (PMID: 32457742)
Front Microbiol. 2018 Dec 04;9:2966. (PMID: 30564215)
Mult Scler. 2020 Dec;26(14):1816-1821. (PMID: 33174475)
Nat Immunol. 2005 Nov;6(11):1063-6. (PMID: 16239917)
Sci Rep. 2021 Aug 5;11(1):15902. (PMID: 34354146)
Zoonoses Public Health. 2021 Nov;68(7):704-718. (PMID: 34169644)
Microorganisms. 2020 Feb 05;8(2):. (PMID: 32033287)
Mult Scler Relat Disord. 2022 Mar;59:103671. (PMID: 35180618)
Semin Immunol. 2014 Dec;26(6):512-7. (PMID: 25444548)
J Neurosci Res. 2013 Oct;91(10):1292-302. (PMID: 23907992)
Prev Vet Med. 2003 Apr 30;58(1-2):1-13. (PMID: 12628767)
Front Cell Neurosci. 2018 Aug 06;12:247. (PMID: 30127724)
J Intern Med. 2020 Dec;288(6):625-640. (PMID: 32128919)
Ecohealth. 2022 Jun;19(2):164-174. (PMID: 35655048)
Front Immunol. 2022 May 03;13:872542. (PMID: 35592323)
Pediatr Infect Dis J. 2018 Oct;37(10):e257-e260. (PMID: 29570591)
Lancet. 1969 Jan 18;1(7586):111-5. (PMID: 4178240)
Cell. 2020 Oct 15;183(2):315-323.e9. (PMID: 32941801)
PLoS Med. 2011 Mar;8(3):e1001012. (PMID: 21445325)
PLoS One. 2010 Mar 03;5(3):e9505. (PMID: 20209079)
Lancet. 1961 Oct 28;2(7209):951-4. (PMID: 13879648)
J Am Geriatr Soc. 2022 Apr;70(4):1157-1168. (PMID: 34897645)
JAMA Netw Open. 2019 Sep 4;2(9):e1912014. (PMID: 31553471)
فهرسة مساهمة: Keywords: Alzheimer’s disease; Bacillus Calmette-Guérin (BCG); Mycobacterium avium ss. paratuberculosis (MAP); Parkinson’s disease; global burden of disease; molecular mimicry; multiple sclerosis; non-tuberculous mycobacteria (NTM); nonspecific effects; trained immunity; tuberculosis; type 1 diabetes
تواريخ الأحداث: Date Created: 20221027 Latest Revision: 20240906
رمز التحديث: 20240906
مُعرف محوري في PubMed: PMC9609351
DOI: 10.3390/microorganisms10101919
PMID: 36296196
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-2607
DOI:10.3390/microorganisms10101919